How do Skytrofa and Sogroya compare side by side?
From the US Skytrofa and Sogroya labels. Each label compares its drug with daily somatropin in children and with placebo in adults, in separate trials. The four rows above are the short version.
Show all 8 rowsHide table
| Skytrofa | Sogroya | |
|---|---|---|
| Drug | Lonapegsomatropin-tcgd1 | Somapacitan-beco2 |
| Children | Age 1 and older, at least 11.5 kg, with growth hormone deficiency1 | Age 2.5 and older with growth hormone deficiency, born small for gestational age, Noonan syndrome or idiopathic short stature2 |
| Child dose | 0.24 mg/kg a week, with the cartridge picked from a weight table1 | 0.16 mg/kg a week for growth hormone deficiency; 0.24 mg/kg for the other uses2 |
| Adult dose | Start 0.7, 1.4 or 2.1 mg a week by age and oral estrogen use; up to 6.3 mg1 | Start 1.5 mg a week (1 mg over 65, 2 mg on oral estrogen); up to 8 mg2 |
| Device | Powder cartridge mixed and injected by the Skytrofa Auto-Injector1 | Three strengths of prefilled pen2 |
| Missed dose | Within 2 days of the missed day; doses at least 5 days apart1 | Within 3 days after the scheduled day2 |
| Adult trial vs placebo | Swelling (edema) 8% vs 1%1 | Back pain 10% vs 3.3%, joint pain 6.7% vs 1.6%2 |
| Boxed warning | None1 | None2 |
Reviewed . Half-life figures are shown only where the value Dose Track uses agrees with the cited source.
What did the child trials show?
Both labels compare the weekly drug with daily somatropin over 52 weeks in children with growth hormone deficiency who had not been treated before. On Skytrofa, viral infection was 15% vs 11% and fever 15% vs 9%.1 On Sogroya, headache was 12.1% vs 8.8% and pain in the arms or legs 9.8% vs 2.9%.2 These numbers come from separate trials with different people, lengths and methods, so they are not a head-to-head comparison.
How do the labels handle switching and warnings?
From daily somatropin, Skytrofa starts at least 8 hours after the last daily dose; from another weekly growth hormone, at least 7 days after its last dose.1 Children on Sogroya take the last daily dose the day before, or at least 8 hours before, the first weekly dose, and children coming from another weekly product keep the weekly schedule.2 Both labels carry the growth hormone class warnings, including critical illness, tumors, blood sugar, raised pressure in the skull, hip problems in children and pancreatitis, and neither is approved for Prader-Willi syndrome growth failure.12
Which, if either, fits is for your prescriber. More detail: Skytrofa side effects, Sogroya side effects, the Skytrofa and Sogroya dosing schedules, the Skytrofa and Sogroya missed-dose pages, and Sogroya vs daily growth hormone: what changes with a weekly shot?.
Frequently asked questions
Which is approved for younger children?
What if I miss a dose?
Have Skytrofa and Sogroya been compared directly?
Neither label reports a trial against the other.
Can Dose Track remind me to take them?
Yes. You can log each injection and set a weekly reminder.
Related comparisons
- Sogroya vs daily growth hormone: what changes with a weekly shot?One shot a week vs one a day
- Norditropin vs Genotropin vs Omnitrope: how do the somatropin brands differ?Three daily growth hormone brands
- Egrifta SV vs Egrifta WR: what is the difference?1.4 mg single-dose vial vs 1.28 mg weekly vial
- Free reconstitution calculatorVial strength and water to syringe units
See also
- Somapacitan: weekly pen, label dosing and half-life
- How to store Sogroya
- Skytrofa vs Ngenla: how do the two weekly growth hormones differ?
- Sogroya vs Ngenla: how do the two weekly growth hormones differ?
- Trulicity vs Victoza: how do the weekly and daily GLP-1 shots differ?
Track it in Dose Track: peptide tracker. Comparing apps? See the best peptide tracker apps.
Sources
- Skytrofa (lonapegsomatropin-tcgd) for injection prescribing information, sections 1, 2, 4, 5 and 6. DailyMed, version of October 26, 2026.
- Sogroya (somapacitan-beco) injection prescribing information and Patient Information, sections 1, 2, 4, 5 and 6. DailyMed, version of March 16, 2026.
All compound comparisons · All compound guides · Peptide tracking in Dose Track